EichorEICHOR
Condition: Ckd Stage 3 Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Ckd Stage 3

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe
Phase 1 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07483372A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · 47 location(s) · Astellas Pharma Global Development, Inc. · NCT05970172A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney D
Phase 3 · 1 location(s) · Kind Pharmaceuticals LLC · NCT07487727ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
Phase 4 · 1 location(s) · Ace Cells Lab Limited · NCT07187713A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infu
Phase 1/Phase 2 · 2 location(s) · AION Healthspan, Inc. · NCT06721143Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes
NA · 2 location(s) · Heba Al-Alwan · NCT06925217Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease
NA · 1 location(s) · Fu Jen Catholic University Hospital · NCT07493642Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Phase 3 · 1 location(s) · Air Force Military Medical University, China · NCT05510323A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Phase 3 · 22 location(s) · Renibus Therapeutics, Inc. · NCT07355062Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hype
Phase 3 · 40 location(s) · University Hospital, Tours · NCT05732727Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
Phase 3 · 9 location(s) · Novartis Pharmaceuticals · NCT05795140Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
NA · 10 location(s) · AquaPass Medical Ltd. · NCT06360380Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
NA · 1 location(s) · Indiana University · NCT07105670Equol and Vascular Function in Women With Chronic Kidney Disease
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT07194590Exercise Activity to Improve Mobility in Patients With CKD and PAD
NA · 3 location(s) · University Hospital of Ferrara · NCT06621264A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With An
Phase 3 · 1 location(s) · Kind Pharmaceuticals LLC · NCT07494409A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemo
Phase 3 · 43 location(s) · Amgen · NCT03633708A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.
EARLY_Phase 1 · 1 location(s) · Cajal Therapeutics Inc. · NCT07577817Urinary Tubular Biomarkers for Chronic Kidney Disease
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06732349Phosphate Assessment in Chronic Kidney Disease Patients Study
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT07368946A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatmen
Phase 3 · 21 location(s) · AMAG Pharmaceuticals, Inc. · NCT03619850AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring
Phase N/A · 1 location(s) · AccurKardia, Inc. · NCT07210021A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Phase 3 · 58 location(s) · Genexine, Inc. · NCT06466785Prediction of Peripheral Neuropathy With Functional Testing
Phase N/A · 1 location(s) · Université catholique de l'Ouest · NCT06933108Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Phase 3 · 95 location(s) · Prokidney · NCT05099770Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)
NA · 21 location(s) · Dr. Schär AG / SPA · NCT05489120Evaluation of the Effect of a Daily Dose of Wakame Seaweed on Reducing Circulating Concentrations of Advanced Glycation
NA · 1 location(s) · Groupe Hospitalier de la Rochelle Ré Aunis · NCT07729683Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal Dise
Phase 4 · 6 location(s) · Hospital Sirio-Libanes · NCT06402851Patiromer and Diet/hrQoL in Chronic Dialysis
Phase 3 · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT06858280A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Phase 3 · 23 location(s) · Amgen · NCT03969329
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.